- Oral presentation
- Open Access
Quantitative myocardial inflammation assessed using a novel USPIO-Magnetic Resonance Imaging acquisition and analysis protocol
© Semple et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Coronary Artery Bypass Graft
- Myocardial Inflammation
- Late Gadolinium Enhancement
- Coronary Artery Bypass Graft Patient
- Remote Myocardium
Ultrasmall superparamagnetic particles of iron-oxide (SUPIO) particles can be used as a magnetic resonance imaging contrast (MRI) agent. Due to their dextran coating and small diameter (<30 nm), they are phagocytised by inflammatory cells .
The aim of this study was to assess whether a novel acquisition/registration USPIO-MRI protocol could be used to assess myocardial cellular inflammation. Myocardial infarction and cardiac surgery was used to model myocardial inflammation . An influx of macrophages can be seen in post-mortem histology, however the dynamics of in vivo patho-physiology is uncertain .
16 patients underwent MRI 2-4 days after ST-elevation myocardial infarction (STEMI) at baseline and 24-hours after intravenous USPIO infusion (4 mg/kg; Ferumoxytol, AMAG; n=10) or no infusion (n=6). Between 5 and 28-days following on-pump coronary artery bypass graft (CABG) surgery, 32 patients underwent the same protocol with all patients receiving USPIO.
3T-MRI (Siemens Medical) was performed to optimise USPIO sensitivity. Baseline and 24-hour multi-echo T2*-weighted sequences were spatially registered to generate an R2* (1/T2*) map to assess USPIO uptake. R2* maps were spatially registered using custom software (Matlab/Analyze) to late gadolinium enhancement (LGE) images to confirm USPIO localisation in the infarct zone. CABG R2* maps were analysed using a standard 17-segment model
Data comparing CABG to MI cohorts was analysed by one-way and repeated measures ANOVA with Dunn's post-test. Data comparing change in R2* values within cohorts was analysed by Wilcoxon matched pairs test.
Consistent with reticuloendothelial uptake, R2* values increased in the liver & spleen following USPIO administration. In the myocardial infarct, there was a large R2* increase from 41.0±12.0 (baseline) to 155±45.0 s-1 (p<0.001) at 24h. A lower magnitude response was seen in the remote myocardium from 39±3.2 to 80±14.9 s-1 (p<0.002), consistent with myocardial inflammation that occurs post infarction [4[.
In CABG patients the R2* signal increased: 45±7s-1 to 118± 22 s-1 at 24h (p<0001). The increase in myocardial R2* values was greater than in the remote myocardium of patients with STEMI, but lower than the infarct zone itself (p<0.001 and p<0.05 respectively).
USPIO are taken up into inflamed myocardial tissue and can be quantitatively assessed using a multi-parameter MRI acquisition protocol with optimised spatial registration analysis based on a custom mutual information algorithm.
This represents a novel imaging technique of assessing myocardial inflammation, as well as providing a useful research tool in investigating tissue inflammation.
Funding was provided by the Medical Research Council, Chest Heart & Stroke Scotland, the British Heart Foundation and the Scottish Universities Physics Alliance.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.